Study Examines How HDAC Inhibitors Affect Gene Expression in Feline Cells
Researchers treated two types of cultured feline cells with four different HDAC inhibitors and analyzed resulting changes in gene expression using RNA sequencing. The study found that feline cells responded differently to these drugs depending on cell type and organ origin, with some similarities to human cell responses but also notable differences. The findings could inform future development of cancer and neurological disease treatments for cats and other mammals.
A new study published on bioRxiv investigated how histone deacetylase (HDAC) inhibitors—drugs being explored for human cancer and neurological disease treatment—affect gene expression in domestic cat cells. Researchers exposed kidney-derived (CRFK) and astrocyte-derived (PG-4) feline cells to four HDAC inhibitors: panobinostat, trichostatin A, valproic acid, and vorinostat. Using RNA sequencing, they found that HDAC inhibitors upregulated genes involved in cell signaling and intercellular communication in both cell types, mirroring effects seen in human cells. However, responses diverged by cell type: kidney cells did not show the cancer-related gene suppression observed in human cells, while astrocyte-derived cells did suppress cancer and cell cycle genes. Notably, valproic acid—traditionally associated with neurological rather than cancer applications—suppressed more cancer-related genes in astrocytes than other inhibitors tested. The authors conclude that organ-specific and species-specific variations in drug response warrant further investigation for potential therapeutic applications in veterinary medicine.
What's missing
The study's own limitations include: the use of cultured cell lines rather than in vivo models, which may not fully represent whole-organism responses; the 24-hour treatment window, which may not capture longer-term effects; and the lack of functional validation of transcriptomic changes (e.g., protein-level confirmation or phenotypic assays). The authors note that comprehensive multi-cell-type, multi-inhibitor comparisons remain rare even in human studies, limiting the ability to contextualize their findings.
What different sources said
- bioRxivCenter
Transcriptomic response to histone deacetylase inhibitors in cultured feline cells
Related
Study Shows Statins Reduce Coenzyme Q in Brain Cells, Impairing Mitochondrial Function
A laboratory study found that statin drugs decrease coenzyme Q levels in astrocytes (brain support cells) by 30-40%, reducing their mitochondrial energy production and increasing oxidative stress. Astrocytes are critical for maintaining brain health and protecting neurons from damage. The findings suggest CoQ10 supplementation may help counteract these effects, though human clinical evidence remains limited.
Study reveals zebrafish larvae exhibit slowly fluctuating directional swim biases driven by internal dynamics
Researchers found that 5-day-old zebrafish larvae display changing directional swim preferences over many hours even in stable environments, contrary to classical models assuming constant individual biases. Computational analysis suggests these fluctuations arise from a non-stationary Markovian process with two independent internal input streams modulating swim direction repetition. The findings suggest animals possess intrinsic mechanisms for generating behavioral variability independent of external stimuli, with implications for understanding how internal states shape adaptive behavior.
Two Small Molecules Show Promise as Broad-Spectrum Coronavirus Inhibitors in Laboratory Study
Researchers found that sennoside A and ceftazidime, two small molecules, can inhibit RNA binding in the nucleocapsid proteins of SARS-CoV-2, SARS-CoV, and MERS-CoV in laboratory experiments. The nucleocapsid protein is highly conserved across coronaviruses and essential for viral replication, making it a potential drug target. The findings suggest these compounds could form the basis for pan-coronavirus antiviral therapies, though further development and clinical testing would be needed.